Viewing StudyNCT00432523



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00432523
Status: COMPLETED
Last Update Posted: 2021-10-18
First Post: 2007-02-07

Brief Title: Immunogenicity and Safety of Concomitant Administration of MMR rHA and VARIVAX by Intramuscular Versus Subcutaneous Route V205C-011
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Conditions & Keywords Data

Conditions:
Name
Varicella
Measles
Mumps
Keywords:
Name View
Prevention of Measles Mumps Rubella and Varicella diseases View